Gene · 2035
EPB41: erythrocyte membrane protein band 4.1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. EPB41: erythrocyte membrane protein band 4.1. Genes, record 2035. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2035
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P11171 | Protein 4.1 | 864 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents23
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 45191 | P11171 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 45197 | P11171 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 6820 | P11171 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1407 | P11171 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1407 | P11171 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 6820 | P11171 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 28090 | P11171 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 28093 | P11171 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 131061 | P11171 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 131064 | P11171 | Espacenet |
1 to 10 of 23
See all 23 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,576
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | EPB41 papers | Newest fiscal year |
|---|---|---|---|
| ZIABC011720 | HIV-1 Gag Assembly and Maturation | 6 | 2025 |
| ZIADA000606 | Structural basis for the functions of dopamine receptors, neurotransmitter transporters, and sigma 1 receptor | 5 | 2025 |
| ZIADK031117 | Development of Drugs Acting at Adenosine Receptors | 5 | 2025 |
| ZIANS002817 | Involvement Of Human Viruses Associated With Chronic Neurologic Disease | 5 | 2025 |
| ZIANS003040 | Translational studies of human viruses and chronic neurologic disease | 5 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 4 | 2025 |
| R01MH054137 | Structure and Function of Dopamine Receptors | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30DK042086 | Center for Interdisciplinary Study of Inflammatory Intestinal DIsorders (C-IID) | 3 | 2025 |
| R01DK103794 | Systematic Genetic Dissection of Human Erythropoiesis | 3 | 2025 |
1 to 10 of 1,576Source NIH's project files
See all 1,576 nih grantsPapers2,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Variants in Two Families With Congenital Cataract by Whole Exome Sequencing. | Mol Genet Genomic Med | 2026 | 42827312 | PubTator, text mining | PubMed |
| Construction and expression of recombinant human elastin with biological activities: effect of wound healing in vitro and in vivo. | Front Bioeng Biotechnol | 2026 | 42787170 | PubTator, text mining | PubMed |
| Protein 4.1 R Suppresses Melanoma Progression by Inhibiting Glycolysis via the PI3K/AKT/mTOR Pathway. | Mol Carcinog | 2026 | 42762516 | PubTator, text mining | PubMed |
| Identification, selection and testing of new antigens for tegumentary Leishmaniasis serological diagnosis. | Exp Parasitol | 2026 | 41974346 | PubTator, text mining | PubMed |
| ANK1 and EPB41 Variants and The Risk of Glucocorticoid-Induced Osteonecrosis. | Arthritis Rheumatol | 2026 | 41920036 | PubTator, text mining | PubMed |
| Protein 4.1R regulates CCDC26 and impacts myeloid leukemia progression. | Cell Signal | 2026 | 41819398 | PubTator, text mining | PubMed |
| Lactate-induced metabolic reprogramming of TAMs impairs antigen presentation capacity via C/EBPα-CD74 axis in oral squamous cell carcinoma. | Clin Transl Med | 2026 | 41804723 | PubTator, text mining | PubMed |
| NKG2D CAR-T cells for solid tumor immunotherapy: advances, challenges, and future directions. | Front Immunol | 2026 | 41756289 | PubTator, text mining | PubMed |
| Placental iron utilisation in fetal growth restriction: alterations in mitochondrial haem synthesis and iron-sulphur cluster assembly pathways. | J Physiol | 2026 | 41697720 | PubTator, text mining | PubMed |
| Genetic Analysis of 23 SNVs of Nine Genes Involved in RBC Membranopathies with the Hematological Parameters of Mexican Patients. | Genet Test Mol Biomarkers | 2026 | 41631466 | PubTator, text mining | PubMed |
1 to 10 of 2,381
See all 2,381 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2035
GET https://conductscience.org/api/genes/v1/2035/patents?page=2